Hyderabad: AIG Hospitals today announced the launch of the ZAP-X®
Gyroscopic Neuro-Radiosurgery® Platform, the first installation of its kind
in South India and only the second in the country, marking a major advancement
in the treatment of brain tumors and complex neurological disorders. Designed
exclusively for intracranial radiosurgery, ZAP-X enables doctors to treat brain
lesions with extreme precision that too without open surgery, without
incisions, and as a day-care procedure.
The system delivers highly focused radiation beams with
sub-millimeter accuracy, targeting tumors and abnormal tissues while sparing
healthy brain structures. For patients, this means a completely non-invasive
treatment that is painless, requires no hospital stay, and allows them to
return to normal life quickly.
Brain tumors and related neurological disorders represent a
growing health burden in India. Traditionally, many of these conditions have
required complex neurosurgery involving craniotomy, prolonged hospitalization,
and significant recovery time. Stereotactic radiosurgery has emerged globally
as a safer alternative for carefully selected cases, and the introduction of
ZAP-X at AIG Hospitals brings one of the world’s most advanced neuro-radiosurgical
technologies to patients across South India.
Speaking on the occasion, Dr. D. Nageshwar Reddy,
Chairman, AIG Hospitals, said “At AIG Hospitals, our vision has always
been to bring the most advanced medical technologies to patients in a manner
that makes high-quality care both accessible and patient-centric. The
introduction of the ZAP-X Gyroscopic Radiosurgery Platform represents a major
step in that direction. Conditions that once required complex brain surgery can
now be treated with extraordinary precision, as a day-care procedure and
without a single incision. For patients and families, this means less trauma,
faster recovery, and renewed hope. We believe this technology will
significantly benefit patients across Telangana, Andhra Pradesh, and
neighboring regions, while further strengthening Hyderabad’s position as a
center of excellence for advanced neurological care.”
The ZAP-X platform is designed to treat a wide range of
intracranial conditions, including benign and malignant brain tumors, brain
metastases, arteriovenous malformations (AVMs), trigeminal neuralgia, and other
complex neurological disorders. Highlighting the clinical scope of the
technology, Dr. Subodh Raju, Director & Head – Neurosurgery, AIG
Hospitals, said “Modern neurosurgery increasingly focuses on precision
and minimal invasiveness. With ZAP-X, we are able to treat several brain
conditions that previously required open surgery or complex radiotherapy
protocols. This includes benign tumors such as meningiomas and acoustic
neuromas, malignant tumors, vascular malformations, and severe facial pain
conditions like trigeminal neuralgia. AIG Hospitals has built a strong
multidisciplinary ecosystem involving neurosurgeons, radiation oncologists,
neuroradiologists, and medical physicists, ensuring that each patient receives
a carefully coordinated treatment plan. Our goal is to deliver the best
possible outcomes while preserving neurological function and quality of life.”
One of the areas where ZAP-X is expected to make a
particularly significant impact is in the treatment of brain metastases, tumors
that spread to the brain from cancers elsewhere in the body, most commonly from
the lung, breast, or melanoma.
Brain metastases are among the most common brain tumors
worldwide. Traditionally, treatment options have included open surgery or
whole-brain radiation therapy, which can expose large areas of the brain to
radiation and may lead to side effects affecting cognition and quality of life.
In contrast, ZAP-X allows doctors to target only the tumor deposits with
extreme precision, minimizing radiation exposure to healthy brain tissue.
Studies have shown that this focused approach can
significantly improve outcomes, especially for patients who may have multiple
small metastases, allowing them to receive effective treatment without the need
for invasive surgery or prolonged hospital stays.
Prof. John R. Adler, renowned neurosurgeon, inventor of
CyberKnife® and ZAP-X®, and one of the world’s foremost pioneers in radiosurgery, emphasized the
broader potential of the technology adding “Radiosurgery has evolved
tremendously over the past three decades, and ZAP-X represents the next
generation of this field. While brain tumors remain a primary indication, the
precision of this technology also opens up exciting possibilities in the treatment
of functional neurological conditions such as trigeminal neuralgia, movement
disorders, and now we are seeing trials to treat depression as well. The goal
has always been to treat disease with surgical accuracy but without the
invasiveness of traditional surgery. It is gratifying to see institutions like
AIG Hospitals bringing this level of innovation to patients in India.”
The installation of ZAP-X at AIG Hospitals also reinforces
Hyderabad’s growing reputation as a hub for advanced healthcare technology and
medical innovation, offering patients access to world-class treatment closer to
home.
With its ability to treat complex brain conditions through
precise, non-invasive, outpatient radiosurgery, the ZAP-X platform is expected
to benefit thousands of patients across India and neighboring regions,
transforming the landscape of brain tumor care and neurological treatment.